Jae Park, MD

About Me

I am a hematologist-oncologist specializing in the care of patients with leukemia. Along with other colleagues on the Leukemia Service at Memorial Sloan Kettering Cancer Center, I am dedicated to providing the best possible care by treating each patient as if he or she were a member of my own family.

As an active translational investigator, I have spent time both in the laboratory and in clinics to bring new and innovative treatments to patients with leukemia. I am particularly interested in developing more-effective and personalized therapies for patients with acute and chronic lymphoid leukemia, and am the lead investigator of a clinical trial using genetically modified T cells to treat patients with chronic lymphocytic leukemia (CLL). I am also a co-principal investigator on several other clinical trials in patients with acute lymphoblastic leukemia (ALL) and CLL.

My ultimate goal as a physician is to develop new and potentially curative therapies for patients with leukemia and to provide compassionate and individualized care to address each patient’s unique needs.

  • Clinical Expertise: Adult Acute and Chronic Leukemias; Lymphoproliferative Disorders; Cellular Immunotherapy
  • Languages Spoken: English; Korean
  • Education: MD, Johns Hopkins School of Medicine
  • Residencies: Internal Medicine - Massachusetts General Hospital
  • Fellowships: Medical Hematology/Oncology - Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Medical Oncology

See My Colleagues


Park JH, Tallman MS. Managing acute promyelocytic leukemia without conventional chemotherapy: is it possible?. Expert Rev Hematol. 2011 Aug;4(4):427-36.

Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM, Tallman MS. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. 2011 Aug 4; 118(5):1248-54.

Park JH, Hedvat CV, Tallman MS. Blood consult: acute myeloid leukemia and the t(8;21)(q22;22). Blood. 2011 Mar 10;117(10):2775-7. 


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.